Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/24/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Needham Starts NeoVolta (NEOV) at Buy
- NextEra to discuss paying about $76 per share for Dominion, Bloomberg News reports
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Campbell Soup (CPB) Declares $0.39 Quarterly Dividend; 7.7% Yield
- KKR launches Helix with over $10 billion to build AI infrastructure
Co-Diagnostics (CODX) Misses Q3 EPS by 10c, Revenues Miss
November 16, 2020 4:07 PM ESTCo-Diagnostics (NASDAQ: CODX) reported Q3 EPS of $0.53, $0.10 worse than the analyst estimate of $0.63. Revenue for the quarter came in at $21.82 million versus the consensus estimate of $32.79 million.
Q3 2020 Highlights:
Company continues COVID-19 test sales and reports $21.8 million of revenue in Q3;Quarterly net income of $15.7 million and net income per diluted common share of $0.53;Year-to-date net income of $29.7 million and $1.07 per... More